Hjem › Perifer arteriesygdom › Kentucky
Perifer arteriesygdom kliniske forsøg i Kentucky
3 studier for Perifer arteriesygdom søger deltagere på steder i Kentucky.
Officiel studietekst (engelsk)
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- Nephrology Associates of Kentuckiana, PSC, Louisville
RekruttererFase 2/3
Alder 18 og opefter · Alle køn · Opdateret 21. sep. 2026 · NCT05485961Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes
- Lexington VA Medical Center, Lexington, KY, Lexington
RekruttererFase 4
Alder 18 og opefter · Alle køn · Opdateret 17. dec. 2025 · NCT02915198Effects of Carnosine In Patients With Peripheral Arterial Disease Patients
- University of Louisville School of Medicine, Department of Medicine, Division of Environmental Medicine, Louisville
- University Surgical Associates, 401 E. Chestnut St, Suite 710, Louisville
- UofL Physicians - Vascular Surgery Associates, 201 Abraham Flexner Way, Suite 1004, Louisville
RekruttererFase 1/2
Alder 40 til 80 · Alle køn · Opdateret 29. maj 2025 · NCT06480760Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.